Towa Pharmaceutical. 

$26.00
5
+$0.00+0% Wednesday 20:00

Statistics

Day High
26
Day Low
26
52W High
26
52W Low
16.83
Volume
100
Avg. Volume
3
Mkt Cap
1.34B
P/E Ratio
6.28
Dividend Yield
0.95%
Dividend
0.25

Upcoming

Dividends

0.95%Dividend Yield
Jun 26
$0.25
Dec 25
$0.26
Jun 25
$0.28
Dec 24
$0.20
Jun 24
$0.19
10Y Growth
9.71%
5Y Growth
11.7%
3Y Growth
10.06%
1Y Growth
N/A

Earnings

6AugExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
-1.3
-0.53
0.23
1
Expected EPS
N/A
Actual EPS
N/A

Financials

7.27%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
1.77BRevenue
128.59MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow TWAPF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
OtsukaLtd.
OTSKY
Mkt Cap36.83B
Otsuka Holdings Co., Ltd. operates in the same pharmaceutical sector, focusing on innovative and generic drug development, directly competing with Towa Pharmaceutical's market.
Chugai Pharmaceutical
CHGCY
Mkt Cap75.31B
Chugai Pharmaceutical Co., Ltd. is known for its biopharmaceuticals and therapeutic products, competing in the same space as Towa Pharmaceutical, especially in Japan.
Santen Pharmaceutical.
SNPHY
Mkt Cap4.33B
Santen Pharmaceutical Co., Ltd. specializes in ophthalmic products but also has a broad range of pharmaceutical products that compete with Towa Pharmaceutical's offerings.
Takeda Pharmaceutical
TKPHF
Mkt Cap55.41B
Teikoku Pharma USA, Inc., a subsidiary of Teikoku Seiyaku Co., Ltd., competes in the development and manufacturing of pharmaceutical products, including generics, similar to Towa Pharmaceutical.
Asahi Kasei
AHKSY
Mkt Cap15.51B
Astellas Pharma Inc. is a global pharmaceutical company that competes with Towa Pharmaceutical in developing and marketing pharmaceutical products for various therapeutic areas.
Takeda Pharmaceutical
TAK
Mkt Cap52.88B
Takeda Pharmaceutical Company Limited operates globally in the pharmaceutical sector, offering a wide range of products that compete with Towa Pharmaceutical's portfolio.
Merck
MRK
Mkt Cap305.12B
Merck & Co., Inc., while based in the US, has a significant global presence and competes in various therapeutic areas covered by Towa Pharmaceutical.
Pfizer
PFE
Mkt Cap137.76B
Pfizer Inc. is a global pharmaceutical giant that competes across a broad range of therapeutic areas, including those targeted by Towa Pharmaceutical.

About

Towa Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sale ethical drugs in Japan. It operates through two segments; Domestic and Overseas. The company provides its products in the therapeutic areas of digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products, as well as provide formulations from Tablets, Capsules, Injectable, Patches, eye drops, and other products. It also offers IT service related to healthcare; disease risk testing services; and quasi drugs. In addition, the company is involved in research and development and production of active pharmaceutical ingredients, intermediates, support business; and planning, development and OEM manufacturing of health foods, pharmaceuticals, general foods, and other miscellaneous merchandizes. The company was founded in 1951 and is headquartered in Osaka, Japan.
Show more...
CEO
Mr. Itsuro Yoshida
Employees
4923
Country
Japan
ISIN
JP3623150004

Listings

0 Comments

Share your thoughts

FAQ

What is Towa Pharmaceutical. stock price today?
The current price of TWAPF is $26.00 USD — it has increased by +0% in the past 24 hours. Watch Towa Pharmaceutical. stock price performance more closely on the chart.
What is Towa Pharmaceutical. stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Towa Pharmaceutical. stocks are traded under the ticker TWAPF.
What is Towa Pharmaceutical. market cap?
Today Towa Pharmaceutical. has the market capitalization of 1.34B
When is the next Towa Pharmaceutical. earnings date?
Towa Pharmaceutical. is going to release the next earnings report on August 06, 2026.
What were Towa Pharmaceutical. earnings last quarter?
TWAPF earnings for the last quarter are -1.51 USD per share, whereas the estimation was 0.68 USD resulting in a -322.77% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Towa Pharmaceutical. revenue for the last year?
Towa Pharmaceutical. revenue for the last year amounts to 1.77B USD.
What is Towa Pharmaceutical. net income for the last year?
TWAPF net income for the last year is 128.59M USD.
Does Towa Pharmaceutical. pay dividends?
Yes, TWAPF dividends are paid semi-annual. The last dividend per share was 0.25 USD. As of today, Dividend Yield (FWD)% is 0.95%.
How many employees does Towa Pharmaceutical. have?
As of July 16, 2026, the company has 4,923 employees.
In which sector is Towa Pharmaceutical. located?
Towa Pharmaceutical. operates in the Health & Wellness sector.
When did Towa Pharmaceutical. complete a stock split?
The last stock split for Towa Pharmaceutical. was on March 27, 2019 with a ratio of 3:1.
Where is Towa Pharmaceutical. headquartered?
Towa Pharmaceutical. is headquartered in Osaka, Japan.